• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多西他赛抑制头颈部癌细胞的体外侵袭。

Docetaxel suppresses invasiveness of head and neck cancer cells in vitro.

机构信息

Department of Otolaryngology, Kyorin University School of Medicine, Tokyo, Japan.

出版信息

Cancer Sci. 2010 Jun;101(6):1382-6. doi: 10.1111/j.1349-7006.2010.01540.x. Epub 2010 Feb 22.

DOI:10.1111/j.1349-7006.2010.01540.x
PMID:20345482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11158951/
Abstract

The combination of docetaxel, cisplatin, and fluorouracil significantly enhances the survival of head and neck cancer patients compared to cisplatin and fluorouracil. We hypothesized that docetaxel may affect invasiveness of the head and neck cancer cells in addition to its tumor-killing effect. Two different head and neck cancer cell lines (HEp-2 and Ca9-22) were treated with docetaxel at IC(10) and IC(50) concentrations. Cell migration and invasive growth was evaluated by wound healing assay and three-dimensional (3D) culture of multicellular tumor spheroids, respectively. Expression levels of possible downstream effectors for cell migration/invasiveness were measured by immunoblotting in conditions with or without docetaxel. Docetaxel, but not cisplatin, suppressed filopodia formation compared with no treatment (control) condition. Consistent with this, docetaxel suppressed two-dimensional (2D) cell migration and 3D cell invasion compared with control or cisplatin. Only docetaxel treated cells exhibited thick tubulin bundle and had lower activity of Cdc42, a member of the Rho family of small GTPases. In conclusion, Docetaxel treatment suppressed migration and invasiveness of head and neck cancer cells in vitro, which is likely to be mediated by regulating Cdc42 activity.

摘要

多西他赛联合顺铂和氟尿嘧啶可显著提高头颈部癌症患者的生存率,优于顺铂和氟尿嘧啶。我们假设多西他赛可能除了具有肿瘤杀伤作用外,还会影响头颈部癌细胞的侵袭性。用多西他赛的 IC(10)和 IC(50)浓度处理两种不同的头颈部癌细胞系(HEp-2 和 Ca9-22)。通过划痕愈合试验和多细胞肿瘤球体的三维(3D)培养分别评估细胞迁移和侵袭性生长。在用或不用多西他赛的条件下通过免疫印迹法测量可能的细胞迁移/侵袭性的下游效应物的表达水平。与未处理(对照)条件相比,多西他赛而非顺铂抑制了丝状伪足的形成。与此一致,与对照或顺铂相比,多西他赛抑制了 2D 细胞迁移和 3D 细胞侵袭。只有用多西他赛处理的细胞表现出厚的微管束,并且 Cdc42(Rho 家族小 GTPase 的成员)的活性较低。总之,多西他赛治疗在体外抑制了头颈部癌细胞的迁移和侵袭性,这可能是通过调节 Cdc42 活性介导的。

相似文献

1
Docetaxel suppresses invasiveness of head and neck cancer cells in vitro.多西他赛抑制头颈部癌细胞的体外侵袭。
Cancer Sci. 2010 Jun;101(6):1382-6. doi: 10.1111/j.1349-7006.2010.01540.x. Epub 2010 Feb 22.
2
Livin enhances chemoresistance in head and neck squamous cell carcinoma.Livin增强头颈部鳞状细胞癌的化疗耐药性。
Oncol Rep. 2017 Jun;37(6):3667-3673. doi: 10.3892/or.2017.5584. Epub 2017 Apr 19.
3
Pre-radiation enhances the cytotoxicity of docetaxel in head and neck squamous cell carcinoma cells.放疗前增强多西他赛对头颈部鳞状细胞癌细胞的细胞毒性。
Oncol Rep. 2010 May;23(5):1339-43. doi: 10.3892/or_00000769.
4
Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.多西他赛和顺铂:治疗局部晚期、复发或转移性头颈部鳞状细胞癌患者的有效方案。欧洲癌症研究与治疗组织早期临床研究组II期研究结果
Ann Oncol. 1999 Jan;10(1):119-22. doi: 10.1023/a:1008360323986.
5
Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.表皮生长因子受体反义寡核苷酸联合多西他赛对头颈部鳞状细胞癌的抗肿瘤作用
Clin Cancer Res. 2003 Oct 15;9(13):5028-35.
6
Does dexamethasone inhibit the antineoplastic effect of cisplatin and docetaxel in head and neck cancer cells?地塞米松是否抑制顺铂和多西他赛在头颈癌细胞中的抗肿瘤作用?
Anticancer Res. 2010 Jan;30(1):123-7.
7
The growth inhibiting effect of docetaxel (Taxotere) in head and neck squamous cell carcinoma xenografts.
Cancer Lett. 1994 Jun 30;81(2):151-4. doi: 10.1016/0304-3835(94)90196-1.
8
Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma.靶向表皮生长因子受体的小分子干扰RNA增强头颈部鳞状细胞癌对顺铂、5-氟尿嘧啶和多西他赛的化疗敏感性。
Cancer Sci. 2006 Oct;97(10):1115-24. doi: 10.1111/j.1349-7006.2006.00287.x.
9
Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis.干扰素诱导的抗病毒蛋白MxA与前列腺癌呈负相关,并调节细胞周期、侵袭以及多西他赛诱导的细胞凋亡。
Prostate. 2015 Feb 15;75(3):266-79. doi: 10.1002/pros.22912. Epub 2014 Oct 18.
10
Docetaxel in head and neck cancer: a review.多西他赛用于头颈癌:综述
Am J Clin Oncol. 1998 Oct;21(5):482-6. doi: 10.1097/00000421-199810000-00013.

引用本文的文献

1
Molecular Targets for Pharmacotherapy of Head and Neck Squamous Cell Carcinomas.头颈部鳞状细胞癌药物治疗的分子靶点
Curr Issues Mol Biol. 2025 Aug 1;47(8):609. doi: 10.3390/cimb47080609.
2
Tubulin-Targeted Therapy in Melanoma Increases the Cell Migration Potential by Activation of the Actomyosin Cytoskeleton─An In Vitro Study.微管靶向治疗通过激活肌动球蛋白细胞骨架增加黑色素瘤的细胞迁移潜能——一项体外研究。
ACS Biomater Sci Eng. 2024 Nov 11;10(11):7155-7166. doi: 10.1021/acsbiomaterials.4c01226. Epub 2024 Oct 22.
3
Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting.用于葡萄糖转运体和低血糖介导肿瘤靶向的聚(聚(D,L)乳酸-乙醇酸)-星型葡萄糖纳米颗粒
Int J Nanomedicine. 2017 Oct 11;12:7453-7467. doi: 10.2147/IJN.S147668. eCollection 2017.
4
A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance.载有五味子甲素-多西他赛的微乳剂通过克服多药耐药性增强食管癌治疗效果。
Drug Deliv. 2017 Nov;24(1):10-19. doi: 10.1080/10717544.2016.1225854.
5
Mechanisms of Invasion in Head and Neck Cancer.头颈癌的侵袭机制
Arch Pathol Lab Med. 2015 Nov;139(11):1334-48. doi: 10.5858/arpa.2014-0498-RA. Epub 2015 Jun 5.

本文引用的文献

1
Concurrent chemoradiotherapy for organ function preservation in advanced patients with hypopharyngeal and laryngeal cancer.同步放化疗用于晚期下咽癌和喉癌患者器官功能保留
Oncol Rep. 2009 Nov;22(5):1163-7. doi: 10.3892/or_00000550.
2
Interference with actin dynamics is superior to disturbance of microtubule function in the inhibition of human ovarian cancer cell motility.在抑制人卵巢癌细胞运动方面,干扰肌动蛋白动力学优于扰乱微管功能。
Biochem Pharmacol. 2008 Sep 15;76(6):707-16. doi: 10.1016/j.bcp.2008.06.014. Epub 2008 Jul 2.
3
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.顺铂和氟尿嘧啶单独使用或与多西他赛联合用于头颈癌治疗。
N Engl J Med. 2007 Oct 25;357(17):1705-15. doi: 10.1056/NEJMoa070956.
4
Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton.微管靶向剂在亚毒性浓度下抑制血管生成,这一过程与Rac1和Cdc42活性的抑制以及内皮细胞骨架的变化有关。
Mol Cancer Ther. 2006 Sep;5(9):2348-57. doi: 10.1158/1535-7163.MCT-06-0242.
5
Cancer statistics, 2006.2006年癌症统计数据。
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
6
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.放疗联合西妥昔单抗治疗头颈部鳞状细胞癌。
N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422.
7
Cdc42 controls the polarity of the actin and microtubule cytoskeletons through two distinct signal transduction pathways.Cdc42通过两条不同的信号转导途径控制肌动蛋白和微管细胞骨架的极性。
J Cell Sci. 2005 Jun 15;118(Pt 12):2579-87. doi: 10.1242/jcs.02385. Epub 2005 May 31.
8
Activation of endogenous Cdc42 visualized in living cells.内源性Cdc42在活细胞中的可视化激活。
Science. 2004 Sep 10;305(5690):1615-9. doi: 10.1126/science.1100367.
9
Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity.三维培养系统作为研究癌细胞侵袭能力和抗癌药物敏感性的模型。
Anticancer Res. 2004 Jul-Aug;24(4):2169-77.
10
The role of chemotherapy for advanced oro and hypopharyngeal cancer.化疗在晚期口腔和下咽癌中的作用。
Auris Nasus Larynx. 2004 Jun;31(2):113-8. doi: 10.1016/j.anl.2004.02.001.